Dimerix Ltd has released a press release.
Update for NASH Pre-Clinical Program
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Dimerix
- 10 Patient Milestone Reached. On Track to Report Trial Data.
- ARC Linkage Grant to progress discovery platform
- DXB requests US FDA pre IND meeting - performance milestone
- Dimerix Receives TGA Special Access Scheme Approval
- Activity Report & Appendix 4C
Later from Dimerix
- Outcomes of DMX-200 pre-IND meeting with the FDA
- Response to ASX Price and Volume Query
- Appendix 4E
- Positive interim analysis of DMX-200 phase II data
- Update presentation - interim data
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix